Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation. [electronic resource]
Producer: 20200408Description: E270-E272 p. digitalISSN:- 1096-8652
- Adult
- Allografts
- Antibodies, Viral -- blood
- Antibody Specificity
- Cyclosporine -- therapeutic use
- Female
- Graft vs Host Disease -- prevention & control
- Humans
- Immunoglobulin G -- blood
- Immunosuppressive Agents -- adverse effects
- Male
- Measles Vaccine
- Measles virus -- immunology
- Middle Aged
- Mycophenolic Acid -- therapeutic use
- Myeloablative Agonists -- adverse effects
- Peripheral Blood Stem Cell Transplantation -- adverse effects
- Tacrolimus -- therapeutic use
- Time Factors
- Transplantation Conditioning -- adverse effects
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.